One-Two Punch: FDA Approves Two New Drugs to Treat Gonorrhea

One-Two Punch: FDA Approves Two New Drugs to Treat Gonorrhea

From Sex+Health by American Sexual Health Association

January 10, 2026 · 15 min

About this episode

Dr. Jeanne Marrazzo discusses the FDA's approval of two new oral medications for treating gonorrhea and their significance in combating antibiotic resistance.

The FDA recently approved two new medications to treat gonorrhea and they are sorely needed. Give a listen as infectious diseases expert Dr. Jeanne Marrazzo explains why the new drugs are so important in providing a more convenient, oral treatment option against an infection that is increasingly resistant to other therapies. About our guest: In 2023, Dr. Marrazzo was appointed as the sixth Director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health. She previously was Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham School of Medicine and as elected to the National Academy of Medicine in 2024. Her research portfolio is broad and includes the relationships between the vaginal microbiome and female reproductive tract infections, HIV pre-exposure prophylaxis, hormonal contraception, and risk of STI/HIV acquisition.

People in this episode

Guest: Dr Jeanne Marrazzo

Topics covered

  • gonorrhea
  • infectious diseases
  • oral treatment
  • antibiotic resistance

Keywords

  • FDA
  • new medications
  • treatment options
  • infectious diseases expert

Mentioned in this episode

Products: new medications for gonorrhea

More episodes of Sex+Health

Explore listener stats, chart rankings, contacts and more on the Sex+Health podcast page.